<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="1479-0556-9-11 pmid: 21699699 doi: 10.1186/1479-0556-9-11 : Review Antiviral drugs against" exact="hepatitis" post="C virus RehmanSidra1sidra_cemb@yahoo.comAshfaqUsman A1usmancemb@gmail.comJavedTariq1tjavedpk@gmail.com[1], collection: 2011epub: 2011-6-691111received: 2011-4-21accepted: 2011-6-23(C)"/>
 <result pre="antiviral targets against HCV via Specifically Targeted Antiviral Therapy for" exact="hepatitis" post="C (STAT-C) approach (in which compounds are designed to"/>
 <result pre="have successively infected with chronic infection and 2-5% have developed" exact="hepatocellular carcinoma" post="per annum. HCV has the capacity to stimulate immunopathological"/>
 <result pre="(ROS) impend indirectly fibrogenetic effects [6] leading to steatosis and" exact="cirrhosis" post="[7]. HCV infection commences while interaction of virions instigate"/>
 <result pre="NS5B RdRp have been appraised. Specifically Targeted Antiviral Therapy for" exact="hepatitis" post="C (STAT-C) approach is now being currently used to"/>
 <result pre="ITMN-191 (R7227) is considered to be helpful in curing chronic" exact="hepatitis" post="C [44]. GS-327073, 5-[{3-(4-chlorophenyl)-5-isoxazolyl} methyl]-2-(2, 3-difluorophenyl)-5H-imidazo [4,5-c] pyridine is"/>
 <result pre="replicons [47]. Novel sulfonamide P4-capped ketoamide second generation inhibitors of" exact="hepatitis" post="C virus NS3 serine protease have been discovered. Discovery"/>
 <result pre="manuscript. References BaldoVBaldovinTTrivelloRFloreaniAEpidemiology of HCV infectionCurr Pharm Des2008141646165410.2174/13816120878474677018673187 RajaNSJanjuaNKEpidemiology of" exact="hepatitis" post="C virus infection in Pakistan. J Microbiol Immunol InfectJ"/>
 <result pre="of a cDNA clone derived from a blood-borne non-A, non-B" exact="viral hepatitis" post="genomeScience198924435936210.1126/science.25235622523562 ReedKERiceCMOverview of hepatitis C virus genome structure, polyprotein"/>
 <result pre="a cDNA clone derived from a blood-borne non-A, non-B viral" exact="hepatitis" post="genomeScience198924435936210.1126/science.25235622523562 ReedKERiceCMOverview of hepatitis C virus genome structure, polyprotein"/>
 <result pre="from a blood-borne non-A, non-B viral hepatitis genomeScience198924435936210.1126/science.25235622523562 ReedKERiceCMOverview of" exact="hepatitis" post="C virus genome structure, polyprotein processing, and protein propertiesCurr"/>
 <result pre="interferon alfa-2b and ribavirin on steatosis in patients infected with" exact="hepatitis" post="CHepatology200338758512829989 BurloneMEBudkowskaAHepatitis C virus cell entry: role of lipoproteins"/>
 <result pre="FeldJJHoofnagleJHMechanism of action of interferon and ribavirin in treatment of" exact="hepatitis" post="CNature200543696797210.1038/nature0408216107837 ZeuzemSFeinmanSVRasenackJHeathcoteEJLaiMYGaneEO'GradyJReichenJDiagoMLinAPeginterferon alfa-2a in patients with chronic hepatitis CN"/>
 <result pre="treatment of hepatitis CNature200543696797210.1038/nature0408216107837 ZeuzemSFeinmanSVRasenackJHeathcoteEJLaiMYGaneEO'GradyJReichenJDiagoMLinAPeginterferon alfa-2a in patients with chronic" exact="hepatitis" post="CN Engl J Med20003431666167210.1056/NEJM20001207343230111106715 De FrancescoRMigliaccioGChallenges and successes in"/>
 <result pre="Med20003431666167210.1056/NEJM20001207343230111106715 De FrancescoRMigliaccioGChallenges and successes in developing new therapies for" exact="hepatitis" post="CNature200543695396010.1038/nature0408016107835 HaoWHerlihyKJZhangNJFuhrmanSADoanCPatickAKDuggalRDevelopment of a novel dicistronic reporter-selectable hepatitis C"/>
 <result pre="therapies for hepatitis CNature200543695396010.1038/nature0408016107835 HaoWHerlihyKJZhangNJFuhrmanSADoanCPatickAKDuggalRDevelopment of a novel dicistronic reporter-selectable" exact="hepatitis" post="C virus replicon suitable for high-throughput inhibitor screeningAntimicrob Agents"/>
 <result pre="for high-throughput inhibitor screeningAntimicrob Agents Chemother2007519510210.1128/AAC.01008-0617060518 TedescoRShawANBambalRChaiDConchaNODarcyMGDhanakDFitchDMGatesAGerhardtWG3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of" exact="hepatitis" post="C virus RNA-dependent RNA polymeraseJ Med Chem20064997198310.1021/jm050855s16451063 ZuckPMurrayEMStecEGroblerJASimonAJStruloviciBIngleseJFloresOAFerrerMA cell-based"/>
 <result pre="beta-lactamase reporter gene assay for the identification of inhibitors of" exact="hepatitis" post="C virus replicationAnal Biochem200433434435510.1016/j.ab.2004.07.03115494142 WangCGaleMJrKellerBCHuangHBrownMSGoldsteinJLYeJIdentification of FBL2 as a"/>
 <result pre="WangCGaleMJrKellerBCHuangHBrownMSGoldsteinJLYeJIdentification of FBL2 as a geranylgeranylated cellular protein required for" exact="hepatitis" post="C virus RNA replicationMol Cell20051842543410.1016/j.molcel.2005.04.00415893726 WatashiKIshiiNHijikataMInoueDMurataTMiyanariYShimotohnoKCyclophilin B is a"/>
 <result pre="RNA replicationMol Cell20051842543410.1016/j.molcel.2005.04.00415893726 WatashiKIshiiNHijikataMInoueDMurataTMiyanariYShimotohnoKCyclophilin B is a functional regulator of" exact="hepatitis" post="C virus RNA polymeraseMol Cell20051911112210.1016/j.molcel.2005.05.01415989969 ZhangJYamadaOSakamotoTYoshidaHIwaiTMatsushitaYShimamuraHArakiHShimotohnoKDown-regulation of viral replication"/>
 <result pre="replication by adenoviral-mediated expression of siRNA against cellular cofactors for" exact="hepatitis" post="C virusVirology200432013514310.1016/j.virol.2003.11.02315003869 AlRHXieYWangYHagedornCHExpression of recombinant hepatitis C virus non-structural"/>
 <result pre="against cellular cofactors for hepatitis C virusVirology200432013514310.1016/j.virol.2003.11.02315003869 AlRHXieYWangYHagedornCHExpression of recombinant" exact="hepatitis" post="C virus non-structural protein 5B in Escherichia coliVirus Res19985314114910.1016/S0168-1702(97)00147-09620206"/>
 <result pre="non-structural protein 5B in Escherichia coliVirus Res19985314114910.1016/S0168-1702(97)00147-09620206 FerrariEWright-MinogueJFangJWBaroudyBMLauJYHongZCharacterization of soluble" exact="hepatitis" post="C virus RNA-dependent RNA polymerase expressed in Escherichia coliJ"/>
 <result pre="coliJ Virol199973164916549882374 SampathAPadmanabhanRMolecular targets for flavivirus drug discoveryAntiviral Res20098161510.1016/j.antiviral.2008.08.00418796313 BartenschlagerRThe" exact="hepatitis" post="C virus replicon system: from basic research to clinical"/>
 <result pre="025, a cyclophilin binding molecule, is highly efficient in clearing" exact="hepatitis" post="C virus (HCV) replicon-containing cells when used alone or"/>
 <result pre="therapy for HCV (STAT-C) inhibitorsAntimicrob Agents Chemother20095396797610.1128/AAC.00939-0819104013 CoelmontLHanoulleXChatterjiUBergerCSnoeckJBobardtMLimPVliegenIPaeshuyseJVuagniauxGDEB025 (Alisporivir) inhibits" exact="hepatitis" post="C virus replication by preventing a cyclophilin A induced"/>
 <result pre="in domain II of NS5APLoS One5e13687 FlintMMullenSDeatlyAMChenWMillerLZRalstonRBroomCEminiEAHoweAYSelection and characterization of" exact="hepatitis" post="C virus replicons dually resistant to the polymerase and"/>
 <result pre="Agents Chemother20095340141110.1128/AAC.01081-0818936191 LudmererSWGrahamDJBootsEMurrayEMSimcoeAMarkelEJGroblerJAFloresOAOlsenDBHazudaDJLaFeminaRLReplication fitness and NS5B drug sensitivity of diverse" exact="hepatitis" post="C virus isolates characterized by using a transient replication"/>
 <result pre="ShiSTHerlihyKJGrahamJPNonomiyaJRahavendranSVSkorHIrvineRBinfordSTatlockJLiHPreclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the" exact="hepatitis" post="C virus RNA-dependent RNA polymeraseAntimicrob Agents Chemother2009532544255210.1128/AAC.01599-0819307358 KimHJSharonABalCWangJAlluMHuangZMurrayMGBassitLSchinaziRFKorbaBChuCKSynthesis and"/>
 <result pre="analogues with interferon-alpha2b and triple combination with ribavirin in the" exact="hepatitis" post="C virus replicon systemAntivir Chem Chemother200819253118610555 KorbaBEElazarMLuiPRossignolJFGlennJSPotential for hepatitis"/>
 <result pre="the hepatitis C virus replicon systemAntivir Chem Chemother200819253118610555 KorbaBEElazarMLuiPRossignolJFGlennJSPotential for" exact="hepatitis" post="C virus resistance to nitazoxanide or tizoxanideAntimicrob Agents Chemother2008524069407110.1128/AAC.00078-0818710916"/>
 <result pre="C virus resistance to nitazoxanide or tizoxanideAntimicrob Agents Chemother2008524069407110.1128/AAC.00078-0818710916 EinavSSobolHDGehrigEGlennJSThe" exact="hepatitis" post="C virus (HCV) NS4B RNA binding inhibitor clemizole is"/>
 <result pre="synergistic with HCV protease inhibitorsJ Infect Dis2026574 LiuZRobidaJMChinnaswamySYiGRobothamJMNelsonHBIrsiglerAKaoCCTangHMutations in the" exact="hepatitis" post="C virus polymerase that increase RNA binding can confer"/>
 <result pre="AHepatology200950253310.1002/hep.2298719489073 YangWZhaoYFabryckiJHouXNieXSanchezAPhadkeADeshpandeMAgarwalAHuangMSelection of replicon variants resistant to ACH-806, a novel" exact="hepatitis" post="C virus inhibitor with no cross-resistance to NS3 protease"/>
 <result pre="of cholesterol and lipid metabolism on host cell structure and" exact="hepatitis" post="C virus replicationBiochem Cell Biol200684677910.1139/o05-14916462891 PezackiJPSaganSMTonaryAMRouleauYBelangerSSupekovaLSuAITranscriptional profiling of the"/>
 <result pre="hepatocyte metabolism and the antiviral state it conveys against the" exact="hepatitis" post="C virusBMC Chem Biol20099210.1186/1472-6769-9-219149867 ChengYTsouLKCaiJAyaTDutschmanGEGullenEAGrillSPChenAPLindenbachBDHamiltonADChengYCA novel class of meso-tetrakis-porphyrin"/>
 <result pre="ChengYTsouLKCaiJAyaTDutschmanGEGullenEAGrillSPChenAPLindenbachBDHamiltonADChengYCA novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against" exact="hepatitis" post="C virus genotype 1b replicons in vitroAntimicrob Agents Chemother54197206"/>
 <result pre="LinTILenzOFanningGVerbinnenTDelouvroyFScholliersAVermeirenKRosenquistAEdlundMSamuelssonBIn vitro activity and preclinical profile of TMC435350, a potent" exact="hepatitis" post="C virus protease inhibitorAntimicrob Agents Chemother2009531377138510.1128/AAC.01058-0819171797 HopkinsSScorneauxBHuangZMurrayMGWringSSmitleyCHarrisRErdmannFFischerGRibeillYSCY-635, a novel"/>
 <result pre="novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of" exact="hepatitis" post="C virus RNA replication in vitroAntimicrob Agents Chemother54660672 HopkinsSHeumanDGavisELalezariJGlutzerEDiMassimoBRusnakPWringSSafety,"/>
 <result pre="and anti-viral activity of SCY-635 in adult patients with chronic" exact="hepatitis" post="C virus infectionJ Hepatol200950Suppl 1S36Smitley SaRYS, plasma, pharmacokinetics, and"/>
 <result pre="and anti-viral activity of SCY-635 in adult patients with chronic" exact="hepatitis" post="C virus infection ShiSTHerlihyKJGrahamJPFuhrmanSADoanCPargeHHickeyMGaoJYuXChauFIn vitro resistance study of AG-021541,"/>
 <result pre="resistance study of AG-021541, a novel nonnucleoside inhibitor of the" exact="hepatitis" post="C virus RNA-dependent RNA polymeraseAntimicrob Agents Chemother20085267568310.1128/AAC.00834-0718070954 SeiwertSDAndrewsSWJiangYSerebryanyVTanHKossenKRajagopalanPTMisialekSStevensSKStoychevaAPreclinical characteristics"/>
 <result pre="virus RNA-dependent RNA polymeraseAntimicrob Agents Chemother20085267568310.1128/AAC.00834-0718070954 SeiwertSDAndrewsSWJiangYSerebryanyVTanHKossenKRajagopalanPTMisialekSStevensSKStoychevaAPreclinical characteristics of the" exact="hepatitis" post="C virus NS3/4A protease inhibitor ITMN-191 (R7227)Antimicrob Agents Chemother2008524432444110.1128/AAC.00699-0818824605"/>
 <result pre="BogenSLArasappanAVelazquezFBlackmanMHuelgasRPanWSiegelENairLGVenkatramanSGuoZDiscovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of" exact="hepatitis" post="C virus NS3 serine protease with favorable pharmacokinetic profiles"/>
 <result pre="of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in" exact="hepatitis" post="C patientsJ Hepatol20084916316910.1016/j.jhep.2008.03.02718486984 ShanGZPengZGLiYHLiDLiYPMengSGaoLYJiangJDLiZRA novel class of geldanamycin derivatives"/>
 <result pre="helicase inhibitorBiochemistry4918221832 Stankiewicz-DrogonAPalchykovskaLGKostinaVGAlexeevaIVShvedADBoguszewska-ChachulskaAMNew acridone-4-carboxylic acid derivatives as potential inhibitors of" exact="hepatitis" post="C virus infectionBioorg Med Chem2008168846885210.1016/j.bmc.2008.08.07418801660 ChenCSChiouCTChenGSChenSCHuCYChiWKChuYDHwangLHChenPJChenDSStructure-based discovery of triphenylmethane"/>
 <result pre="Med Chem2008168846885210.1016/j.bmc.2008.08.07418801660 ChenCSChiouCTChenGSChenSCHuCYChiWKChuYDHwangLHChenPJChenDSStructure-based discovery of triphenylmethane derivatives as inhibitors of" exact="hepatitis" post="C virus helicaseJ Med Chem2009522716272310.1021/jm801190519419203 BorowskiPDeinertJSchalinskiSBretnerMGinalskiKKulikowskiTShugarDHalogenated benzimidazoles and benzotriazoles"/>
 <result pre="benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of" exact="hepatitis" post="C and related virusesEur J Biochem20032701645165310.1046/j.1432-1033.2003.03540.x12694177 BretnerMBaierAKopanskaKNajdaASchoofAReinholzMLipniackiAPiasekAKulikowskiTBorowskiPSynthesis and biological"/>
 <result pre="specifically inhibit subgenomic HCV replicationBioorg Med Chem1851295136 MagaGGemmaSFattorussoCLocatelliGAButiniSPersicoMKukrejaGRomanoMPChiasseriniLSaviniLSpecific targeting of" exact="hepatitis" post="C virus NS3 RNA helicase. Discovery of the potent"/>
 <result pre="protection screen reveals potent inhibitors of multiple stages of the" exact="hepatitis" post="C virus life cycleProc Natl Acad Sci USA10737643769 GastaminzaPWhitten-BauerCChisariFVUnbiased"/>
 <result pre="cycleProc Natl Acad Sci USA10737643769 GastaminzaPWhitten-BauerCChisariFVUnbiased probing of the entire" exact="hepatitis" post="C virus life cycle identifies clinical compounds that target"/>
 <result pre="antipsychotic drugs at human 5-hydroxytryptamine2C receptorsJ Pharmacol Exp Ther200029522623210991983 ZhangHRothwanglKMesecarADSabahiARongLFongHHLamiridosins," exact="hepatitis" post="C virus entry inhibitors from Lamium albumJ Nat Prod2009722158216210.1021/np900549e19904996"/>
 <result pre="inhibitors from Lamium albumJ Nat Prod2009722158216210.1021/np900549e19904996 RakicBClarkeJTremblayTLTaylorJSchreiberKNelsonKMAbramsSRPezackiJPA small-molecule probe for" exact="hepatitis" post="C virus replication that blocks protein foldingChem Biol2006131051106010.1016/j.chembiol.2006.08.01017052609 SupekovaLSupekFLeeJChenSGrayNPezackiJPSchlapbachASchultzPGIdentification"/>
 <result pre="blocks protein foldingChem Biol2006131051106010.1016/j.chembiol.2006.08.01017052609 SupekovaLSupekFLeeJChenSGrayNPezackiJPSchlapbachASchultzPGIdentification of human kinases involved in" exact="hepatitis" post="C virus replication by small interference RNA library screeningJ"/>
 <result pre="library screeningJ Biol Chem2008283293617951261 RakicBSaganSMNoesthedenMBelangerSNanXEvansCLXieXSPezackiJPPeroxisome proliferator-activated receptor alpha antagonism inhibits" exact="hepatitis" post="C virus replicationChem Biol200613233010.1016/j.chembiol.2005.10.00616426968"/>
</results>
